243 related articles for article (PubMed ID: 14684452)
1. Regulation of cellular plasticity cascades in the pathophysiology and treatment of mood disorders: role of the glutamatergic system.
Zarate CA; Du J; Quiroz J; Gray NA; Denicoff KD; Singh J; Charney DS; Manji HK
Ann N Y Acad Sci; 2003 Nov; 1003():273-91. PubMed ID: 14684452
[TBL] [Abstract][Full Text] [Related]
2. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.
Manji HK; Quiroz JA; Sporn J; Payne JL; Denicoff K; A Gray N; Zarate CA; Charney DS
Biol Psychiatry; 2003 Apr; 53(8):707-42. PubMed ID: 12706957
[TBL] [Abstract][Full Text] [Related]
3. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics.
Manji HK; Duman RS
Psychopharmacol Bull; 2001; 35(2):5-49. PubMed ID: 12397885
[TBL] [Abstract][Full Text] [Related]
4. The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders.
Gray NA; Zhou R; Du J; Moore GJ; Manji HK
J Clin Psychiatry; 2003; 64 Suppl 5():3-17. PubMed ID: 12720479
[TBL] [Abstract][Full Text] [Related]
5. Targeting glutamatergic signaling for the development of novel therapeutics for mood disorders.
Machado-Vieira R; Salvadore G; Ibrahim LA; Diaz-Granados N; Zarate CA
Curr Pharm Des; 2009; 15(14):1595-611. PubMed ID: 19442176
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking.
Du J; Quiroz JA; Gray NA; Szabo ST; Zarate CA; Manji HK
Dialogues Clin Neurosci; 2004 Jun; 6(2):143-55. PubMed ID: 22034247
[TBL] [Abstract][Full Text] [Related]
7. Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression.
Du J; Gray NA; Falke C; Yuan P; Szabo S; Manji HK
Ann N Y Acad Sci; 2003 Nov; 1003():378-80. PubMed ID: 14684466
[TBL] [Abstract][Full Text] [Related]
8. Neuroplasticity and cellular resilience in mood disorders.
Manji HK; Moore GJ; Rajkowska G; Chen G
Mol Psychiatry; 2000 Nov; 5(6):578-93. PubMed ID: 11126389
[TBL] [Abstract][Full Text] [Related]
9. Finding the intracellular signaling pathways affected by mood disorder treatments.
Coyle JT; Duman RS
Neuron; 2003 Apr; 38(2):157-60. PubMed ID: 12718851
[TBL] [Abstract][Full Text] [Related]
10. Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants.
Chen G; Hasanat KA; Bebchuk JM; Moore GJ; Glitz D; Manji HK
Psychosom Med; 1999; 61(5):599-617. PubMed ID: 10511011
[TBL] [Abstract][Full Text] [Related]
11. Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder.
Zarate CA; Singh J; Manji HK
Biol Psychiatry; 2006 Jun; 59(11):1006-20. PubMed ID: 16487491
[TBL] [Abstract][Full Text] [Related]
12. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
Einat H; Manji HK
Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
[TBL] [Abstract][Full Text] [Related]
13. Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses.
Du J; Quiroz J; Yuan P; Zarate C; Manji HK
Neuron Glia Biol; 2004 Aug; 1(3):231-43. PubMed ID: 18634600
[TBL] [Abstract][Full Text] [Related]
14. Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders.
Zarate CA; Quiroz J; Payne J; Manji HK
Psychopharmacol Bull; 2002; 36(4):35-83. PubMed ID: 12858143
[TBL] [Abstract][Full Text] [Related]
15. Neuronal plasticity and survival in mood disorders.
Duman RS; Malberg J; Nakagawa S; D'Sa C
Biol Psychiatry; 2000 Oct; 48(8):732-9. PubMed ID: 11063970
[TBL] [Abstract][Full Text] [Related]
16. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
Chen G; Manji HK
Curr Opin Psychiatry; 2006 May; 19(3):313-23. PubMed ID: 16612219
[TBL] [Abstract][Full Text] [Related]
17. Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.
Quiroz JA; Manji HK
Dialogues Clin Neurosci; 2002 Mar; 4(1):73-92. PubMed ID: 22034240
[TBL] [Abstract][Full Text] [Related]
18. Glutamate modulators as novel interventions for mood disorders.
Mathew SJ; Keegan K; Smith L
Braz J Psychiatry; 2005 Sep; 27(3):243-8. PubMed ID: 16224615
[TBL] [Abstract][Full Text] [Related]
19. Mood stabilizers regulate cytoprotective and mRNA-binding proteins in the brain: long-term effects on cell survival and transcript stability.
Chen G; Huang LD; Zeng WZ; K Manji H
Int J Neuropsychopharmacol; 2001 Mar; 4(1):47-64. PubMed ID: 11343630
[TBL] [Abstract][Full Text] [Related]
20. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
